PDE3A and myxoma: Utilizing antibodies against PDE3A, Ki67, CD3, CD8, CD68, and CD206, we employed multiplex immunohistochemical staining to investigate the composition of myxoma cells, T cells, and macrophages in each patient (Fig. 2a, b).